Next Treatments
Back to Eczema

IMG-007

TypeInjection StagePhase 2 Latest updateJun 5, 2026Phase 2 study started

History

Earliest recorded event: Aug 9, 2023. This timeline shows events collected by Eczema Radar and may not include the treatment’s full history. Study details reflect the latest registry record available here.

  • Jun 5, 2026Phase 2 trial startedLong-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis ClinicalTrials.gov NCT07734415
  • Nov 6, 2025Phase 1/2 results posted · Trial stopped earlyA Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD) Why it stopped: Cohort 1 was completed. Cohort 2 was cancelled because data from Cohort 1 provided sufficient information for further development decision. No safety concerns were noted. ClinicalTrials.gov NCT05984784
  • Jun 17, 2025Phase 2 trial startedA Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis ClinicalTrials.gov NCT07037901
  • Apr 26, 2024Trial stopped earlyReason: Cohort 1 was completed. Cohort 2 was cancelled because data from Cohort 1 provided sufficient information for further development decision. No safety concerns were noted. ClinicalTrials.gov NCT05984784

Sources

Trials